The TOPOGRAPH (Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer Pharmaceuticals) database has recently been released by Australian researchers to aid oncologist’s treatment decisions following molecular reports.
The online tool incorporates results from the latest precision medicine studies, including therapies targeted at specific molecular pathways, and aims to provide up-to-date information on potential treatment options.
The platform, developed by researchers at the Garvan Institute of Medical Research, The Kinghorn Cancer Centre (Sydney), and NHMRC Clinical Trials Centre (University of Sydney) will be particularly useful for Australian oncologists due to incorporating Australian-specific factors such as drug approval status and subsidies that impact treatment accessibility.
Therapeutic decision making process in precision oncology
Read the full article Access TOPGRAPH